World's top Pharmaceuticals stocks
Manufacturers and marketers of generic and specialty drugs, as well as researchers and developers of new drugs, medical products and procedures.
Name | Market Cap | Price to Earnings TTM | Dividend Yield % TTM |
---|---|---|---|
LLYEli Lilly and Co | $755.04bn | 57.26 | 0.63% |
NOVO BNovo Nordisk A/S | DKK3.34tn | 34.1 | 1.31% |
JNJ WDJohnson & Johnson | $397.54bn | 20.6 | 2.81% |
JNJJohnson & Johnson | $373.21bn | 17.75 | 3.14% |
ABBVAbbvie | $323.26bn | 47.91 | 3.35% |
MRKMerck & Co | $257.11bn | 13.07 | 3.03% |
ROGRoche Holding AG | CH₣202.30bn | 13.82 | 3.78% |
RORoche Holding AG | CH₣202.30bn | 14.65 | 3.57% |
NOVNNovartis AG | CH₣186.69bn | 16.42 | 3.7% |
AZNAstraZeneca | £164.52bn | 25.59 | 2.19% |
AMGNAmgen | $152.05bn | 37.87 | 3.14% |
PFEPfizer | $148.53bn | 8.86 | 6.37% |
SANSanofi SA | €115.21bn | 17.43 | 4.08% |
CELG RTBristol-Myers Squibb Co | $120.11bn | 0.01 | 5254.99% |
BMYBristol-Myers Squibb Co | $120.11bn | 16.99 | 4% |
GILDGilead Sciences | $115.38bn | 11.6 | 3.31% |
CSLCSL | AU$135.62bn | 33.55 | 1.45% |
MCKMcKesson | $79.82bn | 26.98 | 0.39% |
ZTSZoetis | $79.07bn | 30.95 | 0.95% |
4519Chugai Pharmaceutical Co | ¥11tn | 28.08 | 1.23% |